Review: Cell Dynamics in Malignant Pleural Effusions

被引:18
|
作者
Giarnieri, Enrico [1 ]
Bellipanni, Gianfranco [2 ]
Macaluso, Marcella [2 ]
Mancini, Rita [1 ]
Holstein, Adam Carl [2 ]
Milanese, Carla [2 ]
Giovagnoli, Maria Rosaria [1 ]
Giordano, Antonio [2 ,3 ,4 ]
Russo, Giuseppe [2 ]
机构
[1] Univ Roma La Sapienza, Dept Clin & Mol Med, Fac Med & Psychol, I-00189 Rome, Italy
[2] Temple Univ, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, Philadelphia, PA 19122 USA
[3] Canc Res Ctr, Pascale Fdn Natl Canc Inst, INT CROM, Mercogliano, AV, Italy
[4] Univ Siena, Dept Med & Surg Sci & Neurosci, I-53100 Siena, Italy
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; ENDOTHELIAL GROWTH-FACTOR; CADHERIN GENE-EXPRESSION; BREAST-CANCER CELLS; TUMOR PROGRESSION; MIR-200; FAMILY; LUNG ADENOCARCINOMA; TGF-BETA; PANCREATIC-CANCER;
D O I
10.1002/jcp.24806
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Malignant pleural effusions (MPEs) are a common manifestation found in patients with lung cancer. After cytological and histological confirmation of malignancy, talc pleurodesis still remains the treatment of choice in patients with MPEs resistant to chemotherapy. Despite this, primary challenges include reduced quality of life and life expectancy in general. Therefore, a better understanding of the cell biology of MPEs, along with improvements in treatment is greatly needed. It has recently been demonstrated that MPEs may represent an excellent source for identification of molecular mechanisms within the tumor and its environment. The present review summarizes the current understanding of MPEs cells and tumor microenvironment, and particularly focuses on dissecting the cross-talk between MPEs and epithelial to mesenchymal transition (EMT), inflammation and cancer stem cells. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 50 条
  • [31] Treatment of Malignant Pleural Effusions
    Saka, Hideo
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Management of Malignant Pleural Effusions
    Francesco Grossi
    Maria Cristina Pennucci
    Lucia Tixi
    Mara A. Cafferata
    Andrea Ardizzoni
    Drugs, 1998, 55 : 47 - 58
  • [33] THYMOSTIMULIN IN MALIGNANT PLEURAL EFFUSIONS
    RIMOLDI, R
    BRUNETTA, F
    FIORETTI, M
    BANDERA, M
    GHIONE, M
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 1984, 6 (01): : 53 - 55
  • [34] Management of malignant pleural effusions
    Hsia, David
    Musani, Ali I.
    CURRENT PULMONOLOGY REPORTS, 2012, 1 (02) : 73 - 81
  • [35] TREATMENT OF MALIGNANT PLEURAL EFFUSIONS
    ENGEL, J
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (25) : 812 - 814
  • [36] Management of malignant pleural effusions
    Antony, VB
    Loddenkemper, R
    Astoul, P
    Boutin, C
    Goldstraw, P
    Hott, J
    Panadero, FR
    Sahn, SA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1987 - 2001
  • [37] Management of malignant pleural effusions
    Bennett, R
    Maskell, N
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 296 - 300
  • [38] Management of malignant pleural effusions
    Astoul, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S249 - S250
  • [39] Treatment of malignant pleural effusions
    Hentrich, M
    Hartenstein, R
    INTERNIST, 1997, 38 (08): : 794 - 804
  • [40] Management of malignant pleural effusions
    Antony, VB
    Loddenkemper, R
    Astoul, P
    Boutin, C
    Goldstraw, P
    Hott, J
    Panadero, FR
    Sahn, SA
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 402 - 419